SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CVTX - CV Therapeutics, Inc.

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Todd N. Weisrock who started this subject2/21/2001 8:05:54 PM
From: IRWIN JAMES FRANKEL  Read Replies (1) of 411
 
Acqua Wellington - still investing in biotech!

biz.yahoo.com

February 21, 2001

CV THERAPEUTICS INC (CVTX)
form 8-K
ITEM 5. OTHER EVENTS
On February 20, 2001, the Registrant entered into an amendment to its common stock purchase agreement allowing for the sale of up to an aggregate of $220,000,000 of the Registrant's Common Stock. The shares had been registered pursuant to an effective Registration Statement on Form S-3. Pursuant to the common stock purchase agreement, as amended, the Registrant may sell up to $220,000,000 of the Registrant's Common Stock, at a small discount to the market price, to Acqua Wellington North American Equities Fund, Ltd. ("Acqua Wellington").

The foregoing description is qualified in its entirety by reference to the following document, which is incorporated herein by reference: Amendment No. 1 to Common Stock Purchase Agreement, dated as of February 20, 2001, by and between the Registrant and Acqua Wellington, a copy of which is attached hereto as Exhibit 10.1.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext